Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-20-023626

Chief Medical Officer acquired 5,515 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Detke Michael J. Chief Medical Officer 2020-04-02 Option exercise +5,515 $6.91 $38,109 22,746 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Detke Michael J. Chief Medical Officer 2020-04-02 Option exercise · Stock Option (Right to Buy) −5,515 109,606 D: show line 2 in the form
Loading xslF345X03/doc4.xml…